Kardio-MRT – Kardio-MRT reduziert überflüssige Herzkatheter

Im August erschien im JAMA die erste umfassende Auswertung der CE-MARC 2 Studie aus der Arbeitsgruppe von John Greenwood, Leeds UK (Greenwood 2016). Sie zeigt, dass man bei Patienten mit stabiler Herzsymptomatik die rein diagnostischen Herzkatheter um fast 2/3 reduzieren kann, wenn man entgegen der anerkannten Praxis frühzeitig eine kardiale MRT oder eine Myokardperfusions-Szintigrafie durchführt und nach deren Ergebnis handelt. Dies steht in direktem Widerspruch zu der Risiko-adaptierten Eskalation der Diagnostik, wie sie in den meisten nationalen wie internationalen Leitlinien verankert ist.

• Literatur

• 1 Cheng VY, Berman DS, Rozanski A et al. Performance of the traditional age, sex, and angina typicality-based approach for estimating pretest probability of angiografically significant coronary artery disease in patients undergoing coronary computed tomografic angiography: results from the multinational coronary CT angiography evaluation for clinical outcomes: an international multicenter registry (CONFIRM). Circulation 2011; 124: 2423-2432 1–8
• 2 Greenwood JP, Maredia N, Younger JF et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012; 379: 453-460
• 3 Greenwood JP, Motwani M, Maredia N et al. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial. Circulation 2014; 129: 1129-1138
• 4 Greenwood JP, Ripley DP, Berry C et al. Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. Jama 2016; 316: 1051-1060
• 5 Ripley DP, Brown JM, Everett CC et al. Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): a prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease. American heart journal 2015; 169: 17-24 e1
• 6 Schwitter J, Wacker CM, Wilke N et al. Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial). Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2012; 14: 61
• 7 Takx RA, Blomberg BA, El Aidi H et al. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circulation Cardiovascular imaging 2015; 8